Martin, J.; Cheng, Q.; Laurent, S.A.; Thaler, F.S.; Beenken, A.E.; Meinl, E.; Krönke, G.; Hiepe, F.; Alexander, T.
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2024, 25, 10845.
https://doi.org/10.3390/ijms251910845
AMA Style
Martin J, Cheng Q, Laurent SA, Thaler FS, Beenken AE, Meinl E, Krönke G, Hiepe F, Alexander T.
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2024; 25(19):10845.
https://doi.org/10.3390/ijms251910845
Chicago/Turabian Style
Martin, Jonas, Qingyu Cheng, Sarah A. Laurent, Franziska S. Thaler, Anne Elisabeth Beenken, Edgar Meinl, Gerhard Krönke, Falk Hiepe, and Tobias Alexander.
2024. "B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus" International Journal of Molecular Sciences 25, no. 19: 10845.
https://doi.org/10.3390/ijms251910845
APA Style
Martin, J., Cheng, Q., Laurent, S. A., Thaler, F. S., Beenken, A. E., Meinl, E., Krönke, G., Hiepe, F., & Alexander, T.
(2024). B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus. International Journal of Molecular Sciences, 25(19), 10845.
https://doi.org/10.3390/ijms251910845